APO Research
Talk to an analyst

APO RESEARCH · REPORT

Complement C5 Recombinant Monoclonal Antibody

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Complement C5 Recombinant Monoclonal Antibody Industry Growth and Trends Forecast to 2032

28 December 202591 pages

Choose your research edition.

Industry ResearchComplement C5 Recombinant Monoclonal Antibody Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Complement C5 Recombinant Monoclonal Antibody Industry Growth and Trends Forecast to 203291 pages · $3,450 USDMarket StructureGlobal Complement C5 Recombinant Monoclonal Antibody Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Complement C5 Recombinant Monoclonal Antibody Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Complement C5 Recombinant Monoclonal Antibody Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Complement C5 Recombinant Monoclonal Antibody market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Complement C5 Recombinant Monoclonal Antibody is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Complement C5 Recombinant Monoclonal Antibody is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Complement C5 Recombinant Monoclonal Antibody is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Complement C5 Recombinant Monoclonal Antibody include Alexion Pharmaceuticals, Regeneron Pharmaceuticals, Amgen, Roche and Samsung Bioepis, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Complement C5 Recombinant Monoclonal Antibody market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Complement C5 Recombinant Monoclonal Antibody market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Complement C5 Recombinant Monoclonal Antibody market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Complement C5 Recombinant Monoclonal Antibody.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Complement C5 Recombinant Monoclonal Antibody market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Complement C5 Recombinant Monoclonal Antibody Market by Company

Alexion Pharmaceuticals

Regeneron Pharmaceuticals

Amgen

Roche

Samsung Bioepis

Complement C5 Recombinant Monoclonal Antibody Segment by Type

Eculizumab

Pozelimab

Ravulizumab

Crovalimab

Others

Complement C5 Recombinant Monoclonal Antibody Segment by Application

PNH

CD55 Deficiency

aHUS

Others

Complement C5 Recombinant Monoclonal Antibody Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Complement C5 Recombinant Monoclonal Antibody market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Complement C5 Recombinant Monoclonal Antibody and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Complement C5 Recombinant Monoclonal Antibody.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Complement C5 Recombinant Monoclonal Antibody manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Complement C5 Recombinant Monoclonal Antibody in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Eculizumab Table 2. Major Company of Pozelimab Table 3. Major Company of Ravulizumab Table 4. Major Company of Crovalimab Table 5. Major Company of Others Table 6. Global Complement C5 Recombinant Monoclonal Antibody Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Complement C5 Recombinant Monoclonal Antibody Sales by Type (2021-2026) & (K Units) Table 8. Global Complement C5 Recombinant Monoclonal Antibody Sales Market Share in Volume by Type (2021-2026) Table 9. Global Complement C5 Recombinant Monoclonal Antibody Sales by Type (2021-2026) & (US$ Million) Table 10. Global Complement C5 Recombinant Monoclonal Antibody Sales Market Share in Value by Type (2021-2026) Table 11. Global Complement C5 Recombinant Monoclonal Antibody Price by Type (2021-2026) & (US$/Unit) Table 12. Global Complement C5 Recombinant Monoclonal Antibody Sales by Type (2027-2032) & (K Units) Table 13. Global Complement C5 Recombinant Monoclonal Antibody Sales Market Share in Volume by Type (2027-2032) Table 14. Global Complement C5 Recombinant Monoclonal Antibody Sales by Type (2027-2032) & (US$ Million) Table 15. Global Complement C5 Recombinant Monoclonal Antibody Sales Market Share in Value by Type (2027-2032) Table 16. Global Complement C5 Recombinant Monoclonal Antibody Price by Type (2027-2032) & (US$/Unit) Table 17. North America Complement C5 Recombinant Monoclonal Antibody Sales by Type (2021-2026) & (K Units) Table 18. North America Complement C5 Recombinant Monoclonal Antibody Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Complement C5 Recombinant Monoclonal Antibody Sales by Type (2021-2026) & (K Units) Table 20. Europe Complement C5 Recombinant Monoclonal Antibody Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Complement C5 Recombinant Monoclonal Antibody Sales by Type (2021-2026) & (K Units) Table 22. Asia-Pacific Complement C5 Recombinant Monoclonal Antibody Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Complement C5 Recombinant Monoclonal Antibody Sales by Type (2021-2026) & (K Units) Table 24. Latin America Complement C5 Recombinant Monoclonal Antibody Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Complement C5 Recombinant Monoclonal Antibody Sales by Type (2021-2026) & (K Units) Table 26. Middle East and Africa Complement C5 Recombinant Monoclonal Antibody Sales by Type (2021-2026) & (US$ Million) Table 27. Complement C5 Recombinant Monoclonal Antibody Industry Trends Table 28. Complement C5 Recombinant Monoclonal Antibody Industry Drivers Table 29. Complement C5 Recombinant Monoclonal Antibody Industry Opportunities and Challenges Table 30. Complement C5 Recombinant Monoclonal Antibody Industry Restraints Table 31. Global Complement C5 Recombinant Monoclonal Antibody Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Complement C5 Recombinant Monoclonal Antibody Revenue Market Share by Company (2021-2026) Table 33. Global Complement C5 Recombinant Monoclonal Antibody Sales by Company (2021-2026) & (K Units) Table 34. Global Complement C5 Recombinant Monoclonal Antibody Sales Share by Company (2021-2026) Table 35. Global Complement C5 Recombinant Monoclonal Antibody Market Price by Company (2021-2026) & (US$/Unit) Table 36. Global Complement C5 Recombinant Monoclonal Antibody Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Complement C5 Recombinant Monoclonal Antibody Major Company Production Sites and Headquarters Table 38. Global Complement C5 Recombinant Monoclonal Antibody Company, Product Type & Application Table 39. Global Complement C5 Recombinant Monoclonal Antibody Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Complement C5 Recombinant Monoclonal Antibody by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Complement C5 Recombinant Monoclonal Antibody Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Complement C5 Recombinant Monoclonal Antibody Sales by Region (2021-2026) & (K Units) Table 44. Global Complement C5 Recombinant Monoclonal Antibody Sales Market Share in Volume by Region (2021-2026) Table 45. Global Complement C5 Recombinant Monoclonal Antibody Sales by Region (2021-2026) & (US$ Million) Table 46. Global Complement C5 Recombinant Monoclonal Antibody Sales Market Share in Value by Region (2021-2026) Table 47. Global Complement C5 Recombinant Monoclonal Antibody Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 48. Global Complement C5 Recombinant Monoclonal Antibody Sales by Region (2027-2032) & (K Units) Table 49. Global Complement C5 Recombinant Monoclonal Antibody Sales Market Share in Volume by Region (2027-2032) Table 50. Global Complement C5 Recombinant Monoclonal Antibody Sales by Region (2027-2032) & (US$ Million) Table 51. Global Complement C5 Recombinant Monoclonal Antibody Sales Market Share in Value by Region (2027-2032) Table 52. Global Complement C5 Recombinant Monoclonal Antibody Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 53. Global Complement C5 Recombinant Monoclonal Antibody Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Complement C5 Recombinant Monoclonal Antibody Sales by Application (2021-2026) & (K Units) Table 55. Global Complement C5 Recombinant Monoclonal Antibody Sales Market Share in Volume by Application (2021-2026) Table 56. Global Complement C5 Recombinant Monoclonal Antibody Sales by Application (2021-2026) & (US$ Million) Table 57. Global Complement C5 Recombinant Monoclonal Antibody Sales Market Share in Value by Application (2021-2026) Table 58. Global Complement C5 Recombinant Monoclonal Antibody Price by Application (2021-2026) & (US$/Unit) Table 59. Global Complement C5 Recombinant Monoclonal Antibody Sales by Application (2027-2032) & (K Units) Table 60. Global Complement C5 Recombinant Monoclonal Antibody Sales Market Share in Volume by Application (2027-2032) Table 61. Global Complement C5 Recombinant Monoclonal Antibody Sales by Application (2027-2032) & (US$ Million) Table 62. Global Complement C5 Recombinant Monoclonal Antibody Sales Market Share in Value by Application (2027-2032) Table 63. Global Complement C5 Recombinant Monoclonal Antibody Price by Application (2027-2032) & (US$/Unit) Table 64. North America Complement C5 Recombinant Monoclonal Antibody Sales by Application (2021-2026) & (K Units) Table 65. North America Complement C5 Recombinant Monoclonal Antibody Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Complement C5 Recombinant Monoclonal Antibody Sales by Application (2021-2026) & (K Units) Table 67. Europe Complement C5 Recombinant Monoclonal Antibody Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Complement C5 Recombinant Monoclonal Antibody Sales by Application (2021-2026) & (K Units) Table 69. Asia-Pacific Complement C5 Recombinant Monoclonal Antibody Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Complement C5 Recombinant Monoclonal Antibody Sales by Application (2021-2026) & (K Units) Table 71. Latin America Complement C5 Recombinant Monoclonal Antibody Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Complement C5 Recombinant Monoclonal Antibody Sales by Application (2021-2026) & (K Units) Table 73. Middle East and Africa Complement C5 Recombinant Monoclonal Antibody Sales by Application (2021-2026) & (US$ Million) Table 74. Alexion Pharmaceuticals Company Information Table 75. Alexion Pharmaceuticals Business Overview Table 76. Alexion Pharmaceuticals Complement C5 Recombinant Monoclonal Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Alexion Pharmaceuticals Complement C5 Recombinant Monoclonal Antibody Product Portfolio Table 78. Alexion Pharmaceuticals Recent Development Table 79. Regeneron Pharmaceuticals Company Information Table 80. Regeneron Pharmaceuticals Business Overview Table 81. Regeneron Pharmaceuticals Complement C5 Recombinant Monoclonal Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Regeneron Pharmaceuticals Complement C5 Recombinant Monoclonal Antibody Product Portfolio Table 83. Regeneron Pharmaceuticals Recent Development Table 84. Amgen Company Information Table 85. Amgen Business Overview Table 86. Amgen Complement C5 Recombinant Monoclonal Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Amgen Complement C5 Recombinant Monoclonal Antibody Product Portfolio Table 88. Amgen Recent Development Table 89. Roche Company Information Table 90. Roche Business Overview Table 91. Roche Complement C5 Recombinant Monoclonal Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Roche Complement C5 Recombinant Monoclonal Antibody Product Portfolio Table 93. Roche Recent Development Table 94. Samsung Bioepis Company Information Table 95. Samsung Bioepis Business Overview Table 96. Samsung Bioepis Complement C5 Recombinant Monoclonal Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Samsung Bioepis Complement C5 Recombinant Monoclonal Antibody Product Portfolio Table 98. Samsung Bioepis Recent Development Table 99. North America Complement C5 Recombinant Monoclonal Antibody Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 100. North America Complement C5 Recombinant Monoclonal Antibody Sales by Country (2021-2026) & (K Units) Table 101. North America Complement C5 Recombinant Monoclonal Antibody Sales Market Share by Country (2021-2026) Table 102. North America Complement C5 Recombinant Monoclonal Antibody Sales Forecast by Country (2027-2032) & (K Units) Table 103. North America Complement C5 Recombinant Monoclonal Antibody Sales Market Share Forecast by Country (2027-2032) Table 104. North America Complement C5 Recombinant Monoclonal Antibody Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 105. North America Complement C5 Recombinant Monoclonal Antibody Market Size by Country (2021-2026) & (US$ Million) Table 106. North America Complement C5 Recombinant Monoclonal Antibody Market Share by Country (2021-2026) Table 107. North America Complement C5 Recombinant Monoclonal Antibody Market Size Forecast by Country (2027-2032) & (US$ Million) Table 108. North America Complement C5 Recombinant Monoclonal Antibody Market Share Forecast by Country (2027-2032) Table 109. Europe Complement C5 Recombinant Monoclonal Antibody Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 110. Europe Complement C5 Recombinant Monoclonal Antibody Sales by Country (2021-2026) & (K Units) Table 111. Europe Complement C5 Recombinant Monoclonal Antibody Sales Market Share by Country (2021-2026) Table 112. Europe Complement C5 Recombinant Monoclonal Antibody Sales Forecast by Country (2027-2032) & (K Units) Table 113. Europe Complement C5 Recombinant Monoclonal Antibody Sales Market Share Forecast by Country (2027-2032) Table 114. Europe Complement C5 Recombinant Monoclonal Antibody Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 115. Europe Complement C5 Recombinant Monoclonal Antibody Market Size by Country (2021-2026) & (US$ Million) Table 116. Europe Complement C5 Recombinant Monoclonal Antibody Market Share by Country (2021-2026) Table 117. Europe Complement C5 Recombinant Monoclonal Antibody Market Size Forecast by Country (2027-2032) & (US$ Million) Table 118. Europe Complement C5 Recombinant Monoclonal Antibody Market Share Forecast by Country (2027-2032) Table 119. Asia-Pacific Complement C5 Recombinant Monoclonal Antibody Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 120. Asia-Pacific Complement C5 Recombinant Monoclonal Antibody Sales by Country (2021-2026) & (K Units) Table 121. Asia-Pacific Complement C5 Recombinant Monoclonal Antibody Sales Market Share by Country (2021-2026) Table 122. Asia-Pacific Complement C5 Recombinant Monoclonal Antibody Sales Forecast by Country (2027-2032) & (K Units) Table 123. Asia-Pacific Complement C5 Recombinant Monoclonal Antibody Sales Market Share Forecast by Country (2027-2032) Table 124. Asia-Pacific Complement C5 Recombinant Monoclonal Antibody Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 125. Asia-Pacific Complement C5 Recombinant Monoclonal Antibody Market Size by Country (2021-2026) & (US$ Million) Table 126. Asia-Pacific Complement C5 Recombinant Monoclonal Antibody Market Share by Country (2021-2026) Table 127. Asia-Pacific Complement C5 Recombinant Monoclonal Antibody Market Size Forecast by Country (2027-2032) & (US$ Million) Table 128. Asia-Pacific Complement C5 Recombinant Monoclonal Antibody Market Share Forecast by Country (2027-2032) Table 129. Latin America Complement C5 Recombinant Monoclonal Antibody Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 130. Latin America Complement C5 Recombinant Monoclonal Antibody Sales by Country (2021-2026) & (K Units) Table 131. Latin America Complement C5 Recombinant Monoclonal Antibody Sales Market Share by Country (2021-2026) Table 132. Latin America Complement C5 Recombinant Monoclonal Antibody Sales Forecast by Country (2027-2032) & (K Units) Table 133. Latin America Complement C5 Recombinant Monoclonal Antibody Sales Market Share Forecast by Country (2027-2032) Table 134. Latin America Complement C5 Recombinant Monoclonal Antibody Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 135. Latin America Complement C5 Recombinant Monoclonal Antibody Market Size by Country (2021-2026) & (US$ Million) Table 136. Latin America Complement C5 Recombinant Monoclonal Antibody Market Share by Country (2021-2026) Table 137. Latin America Complement C5 Recombinant Monoclonal Antibody Market Size Forecast by Country (2027-2032) & (US$ Million) Table 138. Latin America Complement C5 Recombinant Monoclonal Antibody Market Share Forecast by Country (2027-2032) Table 139. Middle East and Africa Complement C5 Recombinant Monoclonal Antibody Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 140. Middle East and Africa Complement C5 Recombinant Monoclonal Antibody Sales by Country (2021-2026) & (K Units) Table 141. Middle East and Africa Complement C5 Recombinant Monoclonal Antibody Sales Market Share by Country (2021-2026) Table 142. Middle East and Africa Complement C5 Recombinant Monoclonal Antibody Sales Forecast by Country (2027-2032) & (K Units) Table 143. Middle East and Africa Complement C5 Recombinant Monoclonal Antibody Sales Market Share Forecast by Country (2027-2032) Table 144. Middle East and Africa Complement C5 Recombinant Monoclonal Antibody Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 145. Middle East and Africa Complement C5 Recombinant Monoclonal Antibody Market Size by Country (2021-2026) & (US$ Million) Table 146. Middle East and Africa Complement C5 Recombinant Monoclonal Antibody Market Share by Country (2021-2026) Table 147. Middle East and Africa Complement C5 Recombinant Monoclonal Antibody Market Size Forecast by Country (2027-2032) & (US$ Million) Table 148. Middle East and Africa Complement C5 Recombinant Monoclonal Antibody Market Share Forecast by Country (2027-2032) Table 149. Key Raw Materials Table 150. Raw Materials Key Suppliers Table 151. Complement C5 Recombinant Monoclonal Antibody Distributors List Table 152. Complement C5 Recombinant Monoclonal Antibody Customers List Table 153. Research Programs/Design for This Report Table 154. Authors List of This Report Table 155. Secondary Sources Table 156. Primary Sources List of Figures Figure 1. Complement C5 Recombinant Monoclonal Antibody Image Figure 2. Global Complement C5 Recombinant Monoclonal Antibody Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Complement C5 Recombinant Monoclonal Antibody Market Size (2021-2032) & (US$ Million) Figure 4. Global Complement C5 Recombinant Monoclonal Antibody Sales (2021-2032) & (K Units) Figure 5. Eculizumab Image Figure 6. Global Eculizumab Sales YoY Growth (2021-2032) & (K Units) Figure 7. Pozelimab Image Figure 8. Global Pozelimab Sales YoY Growth (2021-2032) & (K Units) Figure 9. Ravulizumab Image Figure 10. Global Ravulizumab Sales YoY Growth (2021-2032) & (K Units) Figure 11. Crovalimab Image Figure 12. Global Crovalimab Sales YoY Growth (2021-2032) & (K Units) Figure 13. Others Image Figure 14. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 15. Global Complement C5 Recombinant Monoclonal Antibody Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Complement C5 Recombinant Monoclonal Antibody Market Share by Type 2025 VS 2032 Figure 17. North America Complement C5 Recombinant Monoclonal Antibody Sales Market Share in Volume by Type in 2025 Figure 18. North America Complement C5 Recombinant Monoclonal Antibody Sales Market Share in Value by Type in 2025 Figure 19. Europe Complement C5 Recombinant Monoclonal Antibody Sales Market Share in Volume by Type in 2025 Figure 20. Europe Complement C5 Recombinant Monoclonal Antibody Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Complement C5 Recombinant Monoclonal Antibody Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Complement C5 Recombinant Monoclonal Antibody Sales Market Share in Value by Type in 2025 Figure 23. Latin America Complement C5 Recombinant Monoclonal Antibody Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Complement C5 Recombinant Monoclonal Antibody Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Complement C5 Recombinant Monoclonal Antibody Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Complement C5 Recombinant Monoclonal Antibody Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Complement C5 Recombinant Monoclonal Antibody Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. PNH Image Figure 30. Global PNH Sales YoY Growth (2021-2032) & (K Units) Figure 31. CD55 Deficiency Image Figure 32. Global CD55 Deficiency Sales YoY Growth (2021-2032) & (K Units) Figure 33. aHUS Image Figure 34. Global aHUS Sales YoY Growth (2021-2032) & (K Units) Figure 35. Others Image Figure 36. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 37. Global Complement C5 Recombinant Monoclonal Antibody Market Size Overview by Application (2021-2032) & (US$ Million) Figure 38. Global Complement C5 Recombinant Monoclonal Antibody Market Share by Application 2025 VS 2032 Figure 39. North America Complement C5 Recombinant Monoclonal Antibody Sales Market Share in Volume by Application in 2025 Figure 40. North America Complement C5 Recombinant Monoclonal Antibody Sales Market Share in Value by Application in 2025 Figure 41. Europe Complement C5 Recombinant Monoclonal Antibody Sales Market Share in Volume by Application in 2025 Figure 42. Europe Complement C5 Recombinant Monoclonal Antibody Sales Market Share in Value by Application in 2025 Figure 43. Asia-Pacific Complement C5 Recombinant Monoclonal Antibody Sales Market Share in Volume by Application in 2025 Figure 44. Asia-Pacific Complement C5 Recombinant Monoclonal Antibody Sales Market Share in Value by Application in 2025 Figure 45. Latin America Complement C5 Recombinant Monoclonal Antibody Sales Market Share in Volume by Application in 2025 Figure 46. Latin America Complement C5 Recombinant Monoclonal Antibody Sales Market Share in Value by Application in 2025 Figure 47. Middle East and Africa Complement C5 Recombinant Monoclonal Antibody Sales Market Share in Volume by Application in 2025 Figure 48. Middle East and Africa Complement C5 Recombinant Monoclonal Antibody Sales Market Share in Value by Application in 2025 Figure 49. North America Complement C5 Recombinant Monoclonal Antibody Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. North America Complement C5 Recombinant Monoclonal Antibody Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. North America Complement C5 Recombinant Monoclonal Antibody Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. North America Complement C5 Recombinant Monoclonal Antibody Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Complement C5 Recombinant Monoclonal Antibody Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Europe Complement C5 Recombinant Monoclonal Antibody Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Complement C5 Recombinant Monoclonal Antibody Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Europe Complement C5 Recombinant Monoclonal Antibody Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Complement C5 Recombinant Monoclonal Antibody Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Asia-Pacific Complement C5 Recombinant Monoclonal Antibody Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific Complement C5 Recombinant Monoclonal Antibody Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Asia-Pacific Complement C5 Recombinant Monoclonal Antibody Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Complement C5 Recombinant Monoclonal Antibody Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 62. Latin America Complement C5 Recombinant Monoclonal Antibody Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America Complement C5 Recombinant Monoclonal Antibody Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Latin America Complement C5 Recombinant Monoclonal Antibody Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Complement C5 Recombinant Monoclonal Antibody Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 66. Middle East and Africa Complement C5 Recombinant Monoclonal Antibody Sales Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa Complement C5 Recombinant Monoclonal Antibody Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 68. Middle East and Africa Complement C5 Recombinant Monoclonal Antibody Market Share by Country: 2021 VS 2025 VS 2032 Figure 69. Complement C5 Recombinant Monoclonal Antibody Value Chain Figure 70. Key Raw Materials Price Figure 71. Manufacturing Cost Structure Figure 72. Complement C5 Recombinant Monoclonal Antibody Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Eculizumab
  • Pozelimab
  • Ravulizumab
  • Crovalimab
  • Others
Applications
  • PNH
  • CD55 Deficiency
  • aHUS
  • Others
Companies covered
  • Alexion Pharmaceuticals
  • Regeneron Pharmaceuticals
  • Amgen
  • Roche
  • Samsung Bioepis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Complement C5 Recombinant Monoclonal Antibody Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Complement C5 Recombinant Monoclonal Antibody Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Complement C5 Recombinant Monoclonal Antibody Market by Type
  6. 1.3.1 Eculizumab
  7. 1.3.2 Pozelimab
  8. 1.3.3 Ravulizumab
  9. 1.3.4 Crovalimab
  10. 1.3.5 Others
  11. 1.4 Global Complement C5 Recombinant Monoclonal Antibody Market Size by Type
  12. 1.4.1 Global Complement C5 Recombinant Monoclonal Antibody Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Complement C5 Recombinant Monoclonal Antibody Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Complement C5 Recombinant Monoclonal Antibody Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Complement C5 Recombinant Monoclonal Antibody Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Complement C5 Recombinant Monoclonal Antibody Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Complement C5 Recombinant Monoclonal Antibody Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Complement C5 Recombinant Monoclonal Antibody Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Complement C5 Recombinant Monoclonal Antibody Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Complement C5 Recombinant Monoclonal Antibody Industry Trends
  2. 2.2 Complement C5 Recombinant Monoclonal Antibody Industry Drivers
  3. 2.3 Complement C5 Recombinant Monoclonal Antibody Industry Opportunities and Challenges
  4. 2.4 Complement C5 Recombinant Monoclonal Antibody Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Complement C5 Recombinant Monoclonal Antibody Revenue (2021-2026)
  2. 3.2 Global Top Players by Complement C5 Recombinant Monoclonal Antibody Sales (2021-2026)
  3. 3.3 Global Top Players by Complement C5 Recombinant Monoclonal Antibody Price (2021-2026)
  4. 3.4 Global Complement C5 Recombinant Monoclonal Antibody Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Complement C5 Recombinant Monoclonal Antibody Major Company Production Sites & Headquarters
  6. 3.6 Global Complement C5 Recombinant Monoclonal Antibody Company, Product Type & Application
  7. 3.7 Global Complement C5 Recombinant Monoclonal Antibody Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Complement C5 Recombinant Monoclonal Antibody Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Complement C5 Recombinant Monoclonal Antibody Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Complement C5 Recombinant Monoclonal Antibody Tier 1, Tier 2, and Tier 3
4 Complement C5 Recombinant Monoclonal Antibody Regional Status and Outlook
  1. 4.1 Global Complement C5 Recombinant Monoclonal Antibody Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Complement C5 Recombinant Monoclonal Antibody Historic Market Size by Region
  3. 4.2.1 Global Complement C5 Recombinant Monoclonal Antibody Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Complement C5 Recombinant Monoclonal Antibody Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Complement C5 Recombinant Monoclonal Antibody Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Complement C5 Recombinant Monoclonal Antibody Forecasted Market Size by Region
  7. 4.3.1 Global Complement C5 Recombinant Monoclonal Antibody Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Complement C5 Recombinant Monoclonal Antibody Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Complement C5 Recombinant Monoclonal Antibody Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Complement C5 Recombinant Monoclonal Antibody by Application
  1. 5.1 Complement C5 Recombinant Monoclonal Antibody Market by Application
  2. 5.1.1 PNH
  3. 5.1.2 CD55 Deficiency
  4. 5.1.3 aHUS
  5. 5.1.4 Others
  6. 5.2 Global Complement C5 Recombinant Monoclonal Antibody Market Size by Application
  7. 5.2.1 Global Complement C5 Recombinant Monoclonal Antibody Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Complement C5 Recombinant Monoclonal Antibody Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Complement C5 Recombinant Monoclonal Antibody Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Complement C5 Recombinant Monoclonal Antibody Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Complement C5 Recombinant Monoclonal Antibody Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Complement C5 Recombinant Monoclonal Antibody Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Complement C5 Recombinant Monoclonal Antibody Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Complement C5 Recombinant Monoclonal Antibody Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Alexion Pharmaceuticals
  2. 6.1.1 Alexion Pharmaceuticals Company Information
  3. 6.1.2 Alexion Pharmaceuticals Business Overview
  4. 6.1.3 Alexion Pharmaceuticals Complement C5 Recombinant Monoclonal Antibody Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Alexion Pharmaceuticals Complement C5 Recombinant Monoclonal Antibody Product Portfolio
  6. 6.1.5 Alexion Pharmaceuticals Recent Developments
  7. 6.2 Regeneron Pharmaceuticals
  8. 6.2.1 Regeneron Pharmaceuticals Company Information
  9. 6.2.2 Regeneron Pharmaceuticals Business Overview
  10. 6.2.3 Regeneron Pharmaceuticals Complement C5 Recombinant Monoclonal Antibody Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Regeneron Pharmaceuticals Complement C5 Recombinant Monoclonal Antibody Product Portfolio
  12. 6.2.5 Regeneron Pharmaceuticals Recent Developments
  13. 6.3 Amgen
  14. 6.3.1 Amgen Company Information
  15. 6.3.2 Amgen Business Overview
  16. 6.3.3 Amgen Complement C5 Recombinant Monoclonal Antibody Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Amgen Complement C5 Recombinant Monoclonal Antibody Product Portfolio
  18. 6.3.5 Amgen Recent Developments
  19. 6.4 Roche
  20. 6.4.1 Roche Company Information
  21. 6.4.2 Roche Business Overview
  22. 6.4.3 Roche Complement C5 Recombinant Monoclonal Antibody Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Roche Complement C5 Recombinant Monoclonal Antibody Product Portfolio
  24. 6.4.5 Roche Recent Developments
  25. 6.5 Samsung Bioepis
  26. 6.5.1 Samsung Bioepis Company Information
  27. 6.5.2 Samsung Bioepis Business Overview
  28. 6.5.3 Samsung Bioepis Complement C5 Recombinant Monoclonal Antibody Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Samsung Bioepis Complement C5 Recombinant Monoclonal Antibody Product Portfolio
  30. 6.5.5 Samsung Bioepis Recent Developments
7 North America by Country
  1. 7.1 North America Complement C5 Recombinant Monoclonal Antibody Sales by Country
  2. 7.1.1 North America Complement C5 Recombinant Monoclonal Antibody Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Complement C5 Recombinant Monoclonal Antibody Sales by Country (2021-2026)
  4. 7.1.3 North America Complement C5 Recombinant Monoclonal Antibody Sales Forecast by Country (2027-2032)
  5. 7.2 North America Complement C5 Recombinant Monoclonal Antibody Market Size by Country
  6. 7.2.1 North America Complement C5 Recombinant Monoclonal Antibody Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Complement C5 Recombinant Monoclonal Antibody Market Size by Country (2021-2026)
  8. 7.2.3 North America Complement C5 Recombinant Monoclonal Antibody Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Complement C5 Recombinant Monoclonal Antibody Sales by Country
  2. 8.1.1 Europe Complement C5 Recombinant Monoclonal Antibody Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Complement C5 Recombinant Monoclonal Antibody Sales by Country (2021-2026)
  4. 8.1.3 Europe Complement C5 Recombinant Monoclonal Antibody Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Complement C5 Recombinant Monoclonal Antibody Market Size by Country
  6. 8.2.1 Europe Complement C5 Recombinant Monoclonal Antibody Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Complement C5 Recombinant Monoclonal Antibody Market Size by Country (2021-2026)
  8. 8.2.3 Europe Complement C5 Recombinant Monoclonal Antibody Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Complement C5 Recombinant Monoclonal Antibody Sales by Country
  2. 9.1.1 Asia-Pacific Complement C5 Recombinant Monoclonal Antibody Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Complement C5 Recombinant Monoclonal Antibody Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Complement C5 Recombinant Monoclonal Antibody Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Complement C5 Recombinant Monoclonal Antibody Market Size by Country
  6. 9.2.1 Asia-Pacific Complement C5 Recombinant Monoclonal Antibody Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Complement C5 Recombinant Monoclonal Antibody Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Complement C5 Recombinant Monoclonal Antibody Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Complement C5 Recombinant Monoclonal Antibody Sales by Country
  2. 10.1.1 South America Complement C5 Recombinant Monoclonal Antibody Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Complement C5 Recombinant Monoclonal Antibody Sales by Country (2021-2026)
  4. 10.1.3 South America Complement C5 Recombinant Monoclonal Antibody Sales Forecast by Country (2027-2032)
  5. 10.2 South America Complement C5 Recombinant Monoclonal Antibody Market Size by Country
  6. 10.2.1 South America Complement C5 Recombinant Monoclonal Antibody Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Complement C5 Recombinant Monoclonal Antibody Market Size by Country (2021-2026)
  8. 10.2.3 South America Complement C5 Recombinant Monoclonal Antibody Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Complement C5 Recombinant Monoclonal Antibody Sales by Country
  2. 11.1.1 Middle East and Africa Complement C5 Recombinant Monoclonal Antibody Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Complement C5 Recombinant Monoclonal Antibody Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Complement C5 Recombinant Monoclonal Antibody Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Complement C5 Recombinant Monoclonal Antibody Market Size by Country
  6. 11.2.1 Middle East and Africa Complement C5 Recombinant Monoclonal Antibody Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Complement C5 Recombinant Monoclonal Antibody Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Complement C5 Recombinant Monoclonal Antibody Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Complement C5 Recombinant Monoclonal Antibody Value Chain Analysis
  2. 12.1.1 Complement C5 Recombinant Monoclonal Antibody Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Complement C5 Recombinant Monoclonal Antibody Production Mode & Process
  7. 12.2 Complement C5 Recombinant Monoclonal Antibody Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Complement C5 Recombinant Monoclonal Antibody Distributors
  10. 12.2.3 Complement C5 Recombinant Monoclonal Antibody Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst